Fernando Rivero Crespo-rekin lankidetzan egindako argitalpenak (6)

2020

  1. Coronary artery aneurysms, insights from the international coronary artery aneurysm registry (CAAR)

    International Journal of Cardiology, Vol. 299, pp. 49-55

2018

  1. 3-Year Clinical Follow-Up of the RIBS IV Clinical Trial: A Prospective Randomized Study of Drug-Eluting Balloons Versus Everolimus-Eluting Stents in Patients With In-Stent Restenosis in Coronary Arteries Previously Treated With Drug-Eluting Stents

    JACC: Cardiovascular Interventions, Vol. 11, Núm. 10, pp. 981-991

2015

  1. A Prospective Randomized Trial of Drug-Eluting Balloons Versus Everolimus-Eluting Stents in Patients with In-Stent Restenosis of Drug-Eluting Stents the RIBS IV Randomized Clinical Trial

    Journal of the American College of Cardiology, Vol. 66, Núm. 1, pp. 23-33

  2. Erratum: A prospective randomized trial of drug-eluting balloons versus everolimus-eluting stents in patients with in-stent restenosis of drug-eluting stents: The RIBS IV randomized clinical trial (Journal of the American College of Cardiology (2015) 66 (23-33))

    Journal of the American College of Cardiology

  3. Mechanisms of balloon angioplasty and repeat stenting in patients with drug-eluting in-stent restenosis

    International Journal of Cardiology, Vol. 178, pp. 213-220

  4. Rationale and design of the RIBS IV randomised clinical trial (drug-eluting balloons versus everolimus-eluting stents for patients with drug-eluting stent restenosis)

    EuroIntervention, Vol. 11, Núm. 3, pp. 336-342